BioVie

$16.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.32 (-1.90%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BioVie and other stocks, options, and ETFs commission-free!

About BIVI

BioVie Inc. Class A Common Stock, also called BioVie, is a development stage biopharmaceutical company, which discovers, develops, and commercializes drug therapies for liver disease.

CEO
Terren S. Peizer
Employees
—
Headquarters
Santa Monica, California
Founded
2013
Market Cap
238.22M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
43.54K
High Today
$17.41
Low Today
$15.96
Open Price
$16.74
Volume
32.48K
52 Week High
$46.10
52 Week Low
$3.50

BIVI Earnings

-$7.75
-$5.17
-$2.58
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Apr 25, Pre-Market

You May Also Like

PSL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure